CDK19 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.149720E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.117600E-02
Normal-vs-Stage2
1.406060E-02
Normal-vs-Stage3
1.027790E-02
Normal-vs-Stage4
9.834000E-02
Stage1-vs-Stage2
5.001400E-01
Stage1-vs-Stage3
4.240600E-01
Stage1-vs-Stage4
3.874800E-01
Stage2-vs-Stage3
9.325700E-02
Stage2-vs-Stage4
5.205400E-01
Stage3-vs-Stage4
2.877500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.081720E-02
Normal-vs-AfricanAmerican
1.159420E-01
Normal-vs-Asian
3.819600E-02
Caucasian-vs-AfricanAmerican
3.787400E-01
Caucasian-vs-Asian
9.490400E-01
AfricanAmerican-vs-Asian
4.469400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.620100E-03
Normal-vs-Female
2.394400E-02
Male-vs-Female
4.973800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.202400E-02
Normal-vs-Age(41-60Yrs)
1.766250E-02
Normal-vs-Age(61-80Yrs)
1.124010E-02
Normal-vs-Age(81-100Yrs)
2.721500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.971450E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.239000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.526800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.640600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.959040E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.428600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.116200E-02
Normal-vs-Daily Drinker
1.863350E-03
Normal-vs-Weekly Drinker
1.859780E-02
Normal-vs-Occasional Drinker
3.319600E-02
Normal-vs-Social Drinker
2.979500E-02
Non Drinker-vs-Daily Drinker
2.237600E-01
Non Drinker-vs-Weekly Drinker
9.308000E-01
Non Drinker-vs-Occasional Drinker
4.012400E-01
Non Drinker-vs-Social Drinker
7.239600E-01
Daily Drinker-vs-Weekly Drinker
2.276000E-01
Daily Drinker-vs-Occasional Drinker
4.025500E-02
Daily Drinker-vs-Social Drinker
1.395180E-01
Weekly Drinker-vs-Occasional Drinker
4.874800E-01
Weekly Drinker-vs-Social Drinker
8.029000E-01
Occasional Drinker-vs-Social Drinker
6.707200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.687400E-01
Normal-vs-Grade 2
8.805200E-01
Normal-vs-Grade 3
8.105000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.586000E-01
Grade 1-vs-Grade 3
4.496400E-01
Grade 1-vs-Grade 4
8.687400E-01
Grade 2-vs-Grade 3
1.948450E-01
Grade 2-vs-Grade 4
8.805200E-01
Grade 3-vs-Grade 4
8.105000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.276400E-03
Normal-vs-NonDiabetic
6.919400E-03
Diabetic-vs-NonDiabetic
5.000800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.992800E-04
Normal-vs-NoPancreatitis
8.115000E-03
Pancreatitis-vs-NoPancreatitis
1.838570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.275590E-02
Normal-vs-N1
1.554370E-02
N0-vs-N1
9.145000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.938400E-02
Normal-vs-TP53-NonMutant
6.644300E-02
TP53-Mutant-vs-TP53-NonMutant
7.179000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
